The Pituitary

Geben Sie eine Produktbewertung ab.

Autor: Melmed Shlomo (Hrsg.)

CHF 239.00

ISBN: 978-0-323-99899-4

Einband: Fester Einband

Verfügbarkeit: Lieferbar in ca. 10-20 Arbeitstagen

Menge:

+ -

The Pituitary, Fifth Edition continues the tradition of a cogent blend of basic science and clinical medicine. The comprehensive text written by expert pituitary scholars is devoted to the pathogenesis, diagnosis and treatment of pituitary disorders. The new fifth edition has been extensively revised to reflect the most recent data on new research advances in tumorigenesis and new therapeutic approaches for pituitary tumors, particularly in acromegaly and Cushing disease. Notably, new chapters devoted to the Pituitary-Immune Interface and Pituitary Radiotherapy have been included, along with a chapter on Aggressive Pituitary Adenomas developed to align with the WHOs Classification of Pituitary Tumors.

Furthermore, new authors have been invited, ensuring a fresh perspective on critical issues in the field. This extensive body of knowledge is useful for students, trainees, physicians, and scientists who need to understand critical pituitary functions and how to care for patients with pituitary disorders.

Autor	Melmed Shlomo (Hrsg.)
Verlag	Elsevier
Einband	Fester Einband
Erscheinungsjahr	2022
Lieferstatus	Lieferbar in ca. 10-20 Arbeitstagen
Ausgabekennzeichen	Englisch
Masse	H27.6 cm x B21.6 cm x D4.2 cm 2'290 g
Coverlag	Academic Press Inc (Imprint/Brand)
Auflage	5. A.

Über den Autor Melmed Shlomo (Hrsg.)

Shlomo Melmed, MB, ChB, FRCP, MACP, is Executive VP and Dean of the Medical Faculty at Cedars-Sinai Medical Center. He leads Cedars-Sinai's research and education programs, recruiting nationally recognized faculty leadership, establishing new educational programs and maintaining the highest academic standards. Dr. Melmed holds the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine. An international authority on pituitary medicine, he has pioneered the discovery and application of novel treatments for endocrine tumors and has authored more than 350 peer-reviewed articles.Dr. Melmed has been a faculty leader at Cedars-Sinai for nearly 40 years and has been the health system's chief academic officer since 1998. Dr. Melmed's laboratory consistently has received competitive grant awards from the National Institutes of Health since 1980, and he has trained over 80 physicians, scientists and graduate students who occupy leading positions in academic endocrinology worldwide. He is on the editorial board of the Journal of Clinical Investigation and is also an Associate Dean of the UCLA School of Medicine.